Publisher
Springer International Publishing
Reference46 articles.
1. Recommendations for Testing, Managing, and Treating Hepatitis C. Joint panel from the American Association of the Study of Liver Diseases and the Infectious Diseases Society of America. http://www.hcvguidelines.org/. Accessed 8 Jul 2016.
2. European Association for the Study of the Liver Recommendations on Treatment of Hepatitis C. 2015. http://www.easl.eu/medias/cpg/HEPC-2015/Full-report.pdf. Accessed Jul 17 2015.
3. Poynard T, McHutchison JG, Manns M, Trepo C, Lindsay K, Goodman Z, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology. 2002;122(5):1303–13.
4. Simmons B, Saleem J, Hill A, et al. Risk of late relapse or reinfection with Hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis. Clin Infect Dis. 2016;62:683.
5. Ng V, Saab S. Effects of a sustained virologic response on outcomes of patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2011;9:923.